US FDA erratic approach to placebo-controlled trials after issuing an emergency use authorization for a COVID-19 vaccine

Dal-Re Rafael

首页> 外文期刊>Vaccine >US FDA erratic approach to placebo-controlled trials after issuing an emergency use authorization for a COVID-19 vaccine

【24h】

US FDA erratic approach to placebo-controlled trials after issuing an emergency use authorization for a COVID-19 vaccine

机译：美国FDA在发布Covid-19疫苗后发出紧急使用授权后安慰剂对照试验的不稳定方法

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Vaccine》 |2021年第8期|共3页
作者
Dal-Re Rafael;
展开▼
作者单位

Univ Autonoma Madrid Fdn Jimenez Diaz Univ Hosp Hlth Res Inst Epidemiol Unit Avda Reyes Catolicos 2 E-28040 Madrid Spain;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医学免疫学;
关键词
COVID-19; SARS-CoV-2; Candidate vaccines; FDA; Clinical trials; Phase 3 trials; Emergency use authorization; Expanded access;

机译：2019冠状病毒疾病SARS冠状病毒2型候选疫苗;FDA;临床试验;第三阶段试验;紧急使用授权;扩大访问;

相似文献

外文文献
中文文献

1. Immunogenicity and safety of a recombinant fusion protein vaccine(V-01)against coronavirus disease 2019 in healthy adults:a randomized,double-blind,placebo-controlled,phase Ⅱ trial [J] . Ya-Jun Shu, Jian Zhou, Yuan-Qin Min, 中华医学杂志（英文版） . 2021,第016期
2. Immunogenicity and safety of a severe acute respiratory syndrome coronavirus 2 inactivated vaccine in healthy adults:randomized,double-blind,and placebo-controlled phase 1 and phase 2 clinical trials [J] . Hong-Xing Pan, Jing-Xin Li, Dan-Dan Zhu, 中华医学杂志（英文版） . 2021,第011期
3. Next Steps for Efficacy Evaluation in Clinical Trials of COVID-19 Vaccines [J] . Hu-Dachuan Jiang, Li Zhang, Jing-Xin Li, 工程（英文） . 2021,第007期
4. FDA ISSUES EMERGENCY USE AUTHORIZATIONS(EUA)FOR COVID-19 DIAGNOSTICS,VENTILATORS AND SURGICAL MASKS [J] . Biomaterials Forum Group Biomaterials Forum . 2020,第1Suppla期

机译：FDA为Covid-19诊断，呼吸机和外科口罩发出紧急使用授权（EUA）
5. Emergency Use Authorizations (EUAs) Versus FDA Approval: Implications for COVID-19 and Public Health [J] . Zuckerman Diana M. American journal of public health . 2021,第6期

机译：紧急使用授权（EUAS）与FDA批准：对Covid-19和公共卫生的影响
6. Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19 [J] . Daniel D. Rhoads, Sree S. Cherian, Katharine Roman, Journal of Clinical Microbiology . 2020,第8期

机译：雅培申请的比较现在，DiaSorin Simplexa和CDC FDA紧急使用授权方法从诊断患有Covid-19的个体的鼻咽和鼻拭子检测SARS-COV-2的授权方法
7. A-share Stock Reactions to the Approval of COVID-19 Vaccine Clinical Trial: An Event Study Model of Listed Pharmaceutical Firms’ Returns [C] . Xiong Kewei, Liang Yuanyuan International Conference on Economic Management and Model Engineering . 2020

机译：A股股票反应对Covid-19疫苗临床试验的批准：列出的制药公司回报的事件研究模式
8. First COVID-19 Vaccines Receiving the US FDA and EMA Emergency Use Authorization [O] . Andra Fortner, David Schumacher 2021

机译：第一个Covid-19接收美国FDA和EMA紧急使用授权的疫苗
9. Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials [O] . Shilong Yang, Yan Li, Lianpan Dai, 2021

机译：重组串联重复二聚体RBD的蛋白质亚基疫苗（ZF2001）对成人Covid-19的安全性和免疫原性：两种随机，双盲，安慰剂控制，第1期和2阶段试验
10. Human Immunodeficiency Virus Vaccine Challenge: Issues in Development andInternational Trials [R] . 1993

机译：人类免疫缺陷病毒疫苗挑战：发展和国际试验中的问题

US FDA erratic approach to placebo-controlled trials after issuing an emergency use authorization for a COVID-19 vaccine

著录项

相似文献

相关主题

期刊订阅